Clinical examination and all-cause mortality in non-mild COPD population – prospective study
V. Koblizek (Hradec Kralov, Czech Republic), L. Nevoranek (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), K. Neumannova (Olomouc, Czech Republic), B. Novotna (Praha, Czech Republic), M. Skrobakova (Brno, Czech Republic), M. Svoboda (Brno, Czech Republic), R. Simek (Zlin, Czech Republic), P. Safranek (Plzen, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), P. Voglova (Mlada Boleslav, Czech Republic), Z. Liptakova (Ceske Budejovice, Czech Republic), L. Heribanova (Praha, Czech Republic), J. Lnenicka (Praha, Czech Republic), P. Musilova (Jihlava, Czech Republic), K. Brat (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic)
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Session: Long-term evaluation and control of airway diseases
Session type: Thematic Poster
Number: 2597
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Koblizek (Hradec Kralov, Czech Republic), L. Nevoranek (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), K. Neumannova (Olomouc, Czech Republic), B. Novotna (Praha, Czech Republic), M. Skrobakova (Brno, Czech Republic), M. Svoboda (Brno, Czech Republic), R. Simek (Zlin, Czech Republic), P. Safranek (Plzen, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), P. Voglova (Mlada Boleslav, Czech Republic), Z. Liptakova (Ceske Budejovice, Czech Republic), L. Heribanova (Praha, Czech Republic), J. Lnenicka (Praha, Czech Republic), P. Musilova (Jihlava, Czech Republic), K. Brat (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic). Clinical examination and all-cause mortality in non-mild COPD population – prospective study. 2597
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020 Year: 2020
The glycemic gap and 90-day mortality in community-acquired pneumonia- A prospective cohort study Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
All-cause mortality in adults with incident asthma – a 20-year follow-up study of a large population-based cohort of middle-aged Danish adults Source: International Congress 2019 – Long-term lung function: from early birth to adulthood Year: 2019
A prospective study on COPD and risk of mortality five years later Source: Annual Congress 2009 - Risk factors for COPD Year: 2009
Predicting 12-month mortality in a Scottish COPD cohort Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Psychosocial predictors for rapid hospital readmission in COPD: a prospective study Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013 Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016 Year: 2017
Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Five-repetition sit-to-stand and mortality in COPD: a prospective cohort study Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018
Co-morbidities of adult smokers at risk of COPD evaluated in a 6-year prospective study Source: International Congress 2015 – COPD: notable points Year: 2015
Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021
Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020
COPD and its comorbidities – prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007
Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005
Relationship between supernormal lung function and long-term risk of hospitalisations and mortality: a population-based cohort study Source: Eur Respir J, 57 (4) 2004055; 10.1183/13993003.04055-2020 Year: 2021
Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study Source: ERJ Open Res, 8 (1) 00628-2021; 10.1183/23120541.00628-2021 Year: 2022
Influence of statin treatment on cancer mortality in COPD patients: Retrospective observational cohort study Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012